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Summary
Background It seems plausible that children with atopy and persistent asthma symptoms
will, like their adult counterparts, have chronic airways inflammation. However, many
young children with no other atopic features have episodic wheezing that is triggered solely
by viral respiratory infections. Little is known as to whether airways inflammation occurs in
these two asthma patterns during relatively asymptomatic periods.
Methods Using a non-bronchoscopic bronchoalveolar lavage (BAL) procedure on chil-
dren presenting for an elective surgical procedure, this study has investigated the cellular
constituents of BAL fluid in children with a history of atopic asthma (AA) non-asthmatic
atopic children (NAA) or viral associated wheeze (VAW).
Results A total of 95 children was studied: 52 with atopic asthma (8.0 years, range 1.1-
15.3, 36 male), 23 with non-asthmatic atopy (median age 8.3 years, range 1.7-13.6, 11
male) and 20 with VAW (3.1 years, range 1.0-8.2, 13 male). No complications were
observed during the lavage procedure and no adverse events were noted post-operatively.
Total lavage fluid recovered was similar in all groups and the total cell numbers were higher
in the VAW group. Eosinophil (P< 0.005) and mast cell (/ '<0.05) numbers were
significantly elevated in the group with atopic asthma.
Conclusions During relatively asymptomatic periods there is on-going airways inflam-
mation, as demonstrated by eosinophil and mast cell recruitment, in children with asthma
and atopy but not in children with viral associated wheeze or atopy alone. This strongly
suggests that there are different underlying pathophysiologicai mechanisms in these two
groups of children who wheeze.
Keywords: bronchoalveolar lavage, childhood asthma, airways inflammation, eosinophils,
mast cells
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Introduction
Airways inflammation has long been recognized as a char-
acteristic pathological feature of severe fatal asthma [1].
More recently, the presence of airways inflammation in
adult patients with mild atopic asthma has been recognized
[2,3] and it is now thought that the degree of bronchial
Correspondence: Dr M. D. Shields, Department of Child Health, Institute of
Clinical Science, The Queen's University of Belfast, Grosvenor Road,
Belfast BT12 6BJ, UK.
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hyperactivity is related to the extent of the airways inflam-
mation [4]. Little information is available as to whether
these findings also apply to childhood asthma, which may
have several different underlying pathophysiologicai mech-
anisms. Cutz et al. found that the morphological changes in
open lung biopsy specimens of two children with well
controlled asthma were similar to changes observed at
autopsy in two children who died from asthma, although a
larger number of submucosal eosinophils and more exten-
sive epithelial damage were noted in the latter patients [5].
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It is probable that atopic children with asthma (atopic
asthmatics, AA) and who suffer from frequent interval
symptoms will have persisting airways inflammation [6].
However, many children wheeze predominantly in winter
and only in association with a viral respiratory infection
(viral associated wheeze, VAW) and have completely
asymptomatic interval periods [7]. Many of the latter
group of children obtain little or no benefit from the regular
use of preventative anti-inflammatory therapy [8] and it is
possible that these children have a different underlying
pathophysiological mechanism that causes them to wheeze
only with viral infections.
Fibreoptic bronchoscopy with lavage and biopsy has
provided a powerful tool to investigate the airways in
adult asthma. In children such procedures present ethical
difficulties. We have recently established a method for non-
bronchoscopic bronchoalveolar lavage (BAL) in normal
children undergoing elective surgery and have obtained
normal reference intervals for the cellular data [9]. Using
elective surgery as a window of opportunity to overcome
ethical difficulties we have now extended this study to
investigate the occurrence of persisting airways inflamma-
tion in a group of children with a history suggestive of
asthma and whose symptoms were relatively quiescent.
Patients and methods
Patients
Children with a history of current asthma (more than two
wheezing episodes, with at least one episode having
occurred within the previous 12 months) were included.
Children with likely alternative causes of wheezing (e.g.
resolving bronchopulmonary dysplasia, cystic fibrosis, con-
genital heart disease or recurrent aspiration) were excluded.
All children were free from recent respiratory infections. In
addition, children without wheezing but who had evidence
of having other atopic illness were recruited to the study. All
subjects were to undergo an elective surgical procedure for a
non-inflammatory condition at the Royal Belfast Hospital
for Sick Children.
From a detailed asthma and allergy history (Table 1)
usually taken by one of two physicians (GT, MDS) before
the procedure, children were categorized into atopic asth-
matics (AA), viral associated wheeze (VAW) and non-
asthmatic atopies (NAA). Children whose symptoms were
triggered by known aeroallergens, who had other personal
atopic features (e.g. atopic eczema, seasonal rhinitis), a
strong family background of atopy or an elevated serum
IgE compared with age normal values ( > 2 SD from age
normal), were classified as AA. This group of atopic
children were further subdivided into those whose asthma
symptoms were episodic (i.e. with extended asymptomatic
intervals between asthma attacks) and those with persisting
interval symptoms occurring regularly in-between the
asthma attacks. Children with a personal history of atopy
or elevated IgE but without respiratory involvement were
classified as non-asthmatic atopies (NAA). Those children
with no personal or strong family background of atopy,
whose wheezing was predominantly in winter and occurred
solely in association with a viral upper respiratory tract
infection were classified as VAW.
Patients were anaesthetized by one of two anaesthetists
(RT, TG) using a standard anaesthetic protocol as pre-
viously described [9]. Prior to the lavage, children :S5
years were pre-oxygenated for 2-3 breaths. During the
surgical procedure, the anaesthetist made minor adjustments
to the fractional inspired oxygen concentration according to
the oxygen saturation. During the procedure, subsequent
surgery and in the early post-operative period heart rate and
oxygen saturation were continuously monitored. After intu-
bation, a sterile 8 FG graduated neonatal suction catheter
was inserted through the endotrachael tube and wedged in a
distal airway. Lavage was performed with a single 20 mL
aliquot of normal saline and the lavage fluid was immedi-
ately aspirated. Thereafter a blood sample (5 mL) was taken
for determination of serum IgE concentrations (commer-
cially available kit, Pharmacia, Sweden). Post-operatively
pulse, respiratory rate and temperature were recorded every
30 min for 6h and thereafter 4 hourly in those staying
overnight.
Processing of BAL fluid
Total cell counts were performed using a modified Neu-
bauer haemocytometer (BDH Ltd, UK). Differential cell
counting was performed using the glass coverslip method
[10] using the modification of Walters and Gardiner [11].
The coverslip preparations were fixed and stained with
Diff-Quik® (Baxter Healthcare Ltd, UK) for differential
cell counting with at least 500 cells counted per cover-
slip. Two coverslips were fixed in Camoy's solution (2h)
followed by staining with toluidine blue (0.5% in 0.5 m
HCl, 30 min) for mast cell counts and 2000-5000 cells
counted per coverslip. All counts were performed by an
observer who was not aware of the subject's clinical
condition.
Statistical analysis
Except where otherwise stated data are presented as median
and range. Statistical comparisons, where shown, were
performed using the Mann-Whitney f/-test and the Krus-
kal-Wallis ANOVA test. P<Q.Q5 was considered statistically
significant.
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Ethical approval
Writteti informed consetit was obtained from the parents of
subjects taking part in the study and the study was approved
by the Research Ethical Committee of the Faculty of
Medicine, The Queen's University of Belfast.
Results
Patient and post-operative data
Ninety-nine children were recruited to the study. Four
subjects were excluded from the study. In two cases there
was an insufficient lavage return and two samples did not
undergo analysis because of red blood cell contamination
(n=l) and mucous (n=l) . The patient characteristics are
summarized in Table 2.
Plastic surgical procedures were the most common elec-
tive operations (n = 59) and overall the most common
procedures were removal of skin or mucous membrane
lesions (34), correction of prominent ears (24), urological
interventions (17) and tonsils and adenoids (6). The lavage
procedure took 1 min. However, in four cases the lavage
was repeated as the catheter did not wedge correctly.
No complications were observed during the lavage proce-
dure, although two patients required a slight temporary
increase in inspired O2 concentration immediately post
lavage. The anaesthetist did not report any problems caused
by the procedure. Heart rate and respiratory rate were
recorded post-operatively and no adverse events were
noted. It is uncertain whether the mild transient pyrexias
observed post-operatively in 11 ofthe 99 patients were related
to the BAL or occurred as a normal post-operative finding. In
addition, the majority of children were given routine anal-
gesic medication which also has anti-pyretic actions.
Atopic children with (n = 52) or without (n = 23) asthma
were significantly older than those with viral associated
wheeze (n = 20) (Table 2). The majority of children in both
groups with wheeze were boys.
Lavage data
The lavage fiuid recovered was similar in all groups [NAA
30.0% of the infused fluid (range 15.0-42.5); AA 30.0%
(10.0-50.0); VAW 32.5% (20.0-45.0)]. The total number
of cells recovered for the VAW group [1.36 x 10^ cells per
mL BAL fiuid (0.3-3.43)] was significantly higher than for
the NAA (P = 0.0008) (0.6x10^ cells per mL BAL fiuid
(range 0.23-1.43) and for the AA (P = 0.015) (0.83x10^
cells per mL BAL fluid (range 0.18-2.50). Differential cell
counts are summarized in Table 3. Eosinophils and mast cell
percentages were significantly elevated in the group with
AA compared with the groups with non-asthmatic atopy or
viral associated wheeze (Table 3, Fig. 1). Since the children
with viral associated wheeze were younger than those with
atopic asthma, we also compared the differential cell counts
for the under-5s in both groups with wheeze (Table 4, Fig.
1). Only the elevation in eosinophil percentages achieved
statistical significance in the under 5 year olds with AA
compared with the VAW (P = 0.0007), although mast cell
percentages were on average doubled in this group. Using
an age-matched sample (n-l6 each in AA and VAW),
again eosinophil (P = 0.016) but not mast cell percentages
were significantly elevated in the AA group (data not
shown). All other cell types did not differ significantly.
Dividing the children according to sex revealed no
statistically significant differences (data not shown).
Dividing the children with atopic asthma into those with
persisting interval symptoms (n = 28) and those with episo-
dic exacerbations without interval symptoms (n - 24), mast
cell and eosinophil numbers were similar in both these
groups (Fig. 2). Eosinophils were significantly elevated in
children with episodic atopic asthma compared with those
with viral associated wheeze (P = 0.006).
Thirty one atopic asthmatic and 10 children with VAW
were currently under treatment with anti-inflammatory anti-
asthma medication (inhaled corticosteroids or cromogly-
cate j . When all wheezing children were considered together
or atopic asthmatics were considered separately, the use of
anti-inflammatory medication was not associated with
significant effects on cell differentials (data not shown).
However, when the VAW was considered separately, those
children on anti-inflammatory medication had reduced mast
cell percentages (f = 0.007) (data not shown).
Discussion
This study clearly demonstrates that even during relatively
asymptomatic periods, there is on-going airways inflamma-
tion, as demonstrated by the recruitment of eosinophils and
mast cells, in children with atopic asthma but not in those
children with viral associated wheeze. This strongly sug-
gests that there are different underlying pathophysiologicai
mechanisms in these two groups of children who wheeze. It
is possible that adverse airways geometry makes VAW
children prone to wheeze with viral infections [12]. In
addition, viral and bacterial products are both able to
cause mediator release directly and to modulate the
response to other secretory stimuli [13,14] and the mast
cells or basophils from children with viral associated
wheeze may be particularly sensitive to this activation
mechanism. Our data provide a possible explanation as to
why children with VAW, who do not appear to have chronic
airways inflammation, do not respond as well to regular
anti-inflammatory treatment [8].
The children were classified according to their clinical
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Table 1. Study questionnaire (administered by a doctor)
BRONCHOLAVEOLAR LAVAGE IN CHILDREN
Name: RBHSC#:
(Study no.
Date of Study
DOB Surgical procedure:
Sex Tel no.
1. Has your child ever been wheezy
2. Has your child ever had a problem with prolonged bouts of coughing
3. When was your child last wheezy?
At what age did they first start wheezing?
4. What makes your child wheeze or cough
a) URTI Yes/No
b) Exercise Yes/No
c) Emotion, e.g. excitement Yes/No
d) Grass or tree pollen Yes/No Specify
e) Animals/pets Yes/No Specify
f) Weather changes Yes/No
g) Which is the worst season?
h) Cigarette smoke or other fumes Yes/No
i) Particular location (eg other house) Yes/No
j) Dusting/vacuuming Yes/No
5. Has your child ever been diagnosed as having asthma? Yes/No
When was this diagnosis made?
6. How frequently typically does your child wheeze or cough?
Yes/No
Yes/No
Cat
D o g _
Others
Last month In last 3 months In last 12 months
No. of asthma attacks
Days/week wheezy or coughing
Nights/week wheezy or coughing
No. hospital admissions for asthma
Days off school for asthma
No. of courses of steroids
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Table 1. Continued
7. Does your child have:
Your child's medication for asthma
eczema (atopic)
hay fever
allergic conjunctivitis
Yes/No
Yes/No
Yes/No
Drug name Dose/Freq. Regular or
when required
How long on
this medication
Drug delivery
method
Problems e.g. with
compliance
Your family history
Asthma Yes/No Atopic eczema
Yes/No
Other allergies Yes/No
eg Hayfever
Smoker Yes/No
Father
Mother
Sibling
Sibling 2
Sibling 3
10. CLINICAL EXAMINATION
Atopic eczema present: Yes/No
Evidence of allergic rhinitis (eg "allergic salute") Yes/No
Chest shape Overinflated (barrel) Yes/No
Harrison's suici Yes/No
Comment
Comment
1997 Blackwell Science Ltd, Clinical and Experimental Allergy, 27, 1027-1035
1032 E. C. Stevenson et al.
Table 2. Characteristics of the three patient groups
Non-asthmatic atopies
(NAA)
Atopic Asthmatics
(AA)
Viral associated wheeze
(VAW)
Number
Age (years)
Sex (M/F)
Present anti-asthma treatment:
No treatment
Bronchodilators alone
Disodium cromoglycate
(DSCG) alone
Inhaled corticosteroids (ICS)
Serum IgE (kU IgE/L)
23
8.3 (1.7-13.6)*
11/12
23
214 (32- > 1000)
52
8.0(1.1-15.3)*
36/16
7
15
4
26
92.3 (3.9- > 1000)
20
3.1 (1.9-8.2)
12/8
4
6
1
5.0 (< 2-100)
All children receiving inhaled corticosteroids also took bronchodilators on an as required basis. In addition, four of the atopic asthmatic
children taking inhaled corticosteroids were additionally receiving saimeterol, three theophylline and one DSCG. One ofthe VAW children
taking inhaled corticosteroids was also receiving DSCG.
All data is presented as absolute number or median (range).
Statistical comparisons were made between the two groups using the Mann-Whitney [/-test. * = F<0.001, compared to VAW group.
Table 3. Differential cell counts for lavage fluid for atopic asthma and viral associated wheeze pattems of asthma
Cell type (%)
Non-asthmatic atopies
(n = 23)
Median (range) Mean ± SEM
Atopic asthmatics
(n = 52)
Median (range) Mean ± SEM
Viral associated wheeze
(n = 20)
Median (range) Mean ± SEM
Macrophage 72.1 (26.5-97.12)
Lymphocyte
Eosinophil
Neutrophil
Epithelial cells
Mast cells
2.2 (0.0-6.0)
0.2 (0.0-9.8)**
3.8 (0.4-15.5)
19.3(1.0-71.8)
0.14(0.0-0.49)**
70.4 ± 4.4
2.1 ± 0.4
0.9 ± 0.4
4.7 ± 0.7
21.8 ± 4.3
0.18 ± 0.04
71.3(25.4-93.8)
1.4 (0.0-10.0)
1.1 (0.0-26.2)
3.5 (0.2-33.2)
14.1 (1.1-56.3)
0.33(0.0-1.15)
69.1 ± 2.5 64.2(25.6-91.2)
1.9 ± 0.3
2.5 ± 0.6
8.2 ± 1.4
18.2 ± 2.0
0.39 ± 0.04
2.3(0.1-12.3)
0.2(0.0-1.1)***
9.0 (0.6-69.1)
16.5 (1.6-54.4)
0.14(0.0-0.76)*
62.1 ± 4.7
3.4 ± 0.7
0.2 ± 0.6
14.8 ± 4.1
19.4 ± 3.7
0.22 ± 0.04
* = f <0.05, ** = P < 0.005 and *** = P < 0.0005 compared to the atopic asthamtic group.
Table 4. Differential cell counts for lavage fluid for atopic asthma and viral associated wheeze pattems of asthma from children under 5
years old
Cell type (%)
Atopic asthmatics
(tl = 15)
Median (range) Mean ± SEM
Viral associated wheeze
(n = 14)
Median (range) Mean ± SEM
Macrophage
Lymphocyte
Eosinophil
Neutrophil
Epithelial cells
Mast cells
67.09 (46.2-90.2)
1.9(0.2-4.4)
1.1 (0.1-6.4)*
5.0 (0.4-33.2)
16.1 (1.1-39.2)
0.32 (0.0-1.06)
67.6 ± 4.1
1.8 ± 0.3
2.1 ± 0.6
11.4 ± 3.4
17.1 ± 3.2
0.40 ±0.10
53.6 (25.6-90.3)
2.3(0.1-12.3)
0.2 (0.0-0.4)
9.0(0.6-69.1)
24.1 (2.4-54.4)
0.15(0.02-0.49)
55.1 ± 5.4
3.3 ± 0.9
0.2 ± 0.03
17.6 ± 5.7
23.8 ± 4.8
0.20 ± 0.04
* =P<0.00\.
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Fig. 1. Eosinophil (a) and mast cell (b) percentages in lavage fluid
from children with atopic asthma {n = 52), viral associated wheeze
(n = 20) and atopy without respiratory disease (n = 23). The results
have been divided according to whether the children were above or
below 5 years of age. Over all age groups both eosinophil
(f £0.005) and mast cell (/'<0.05) percentages were signifi-
cantly elevated in the group with atopic asthma compared with the
other groups. Considering the under 5-year-old children only,
eosinophil numbers were significantly elevated (P<0.001) in the
atopic asthma group compared with the group with viral associated
wheeze.
history aided by the serum IgE concentration. The serum
concetitratioti of IgE is sigtiificatitly elevated in most
patients with allergic diseases such as extrinsic asthma,
hay fever and atopic diseases. It is well known that many
young children with the clinical pattern of viral associated
wheeze will soon outgrow their symptoms, whereas a
smaller number go on to develop more classical atopic
asthma [15,16]. The differences in eosinophil numbers we
found between AA and YAW are unlikely to be due to the
1 25r
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Persistent
atopic asthma
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wheeze
Fig. 2. Eosinophil (a) and mast cell (b) percentages in lavage fiuid
from children with atopic asthma divided according whether the
symptoms were episodic (n = 24) or persistent (n = 28). For com-
parative purposes the data from children with viral associated
wheeze has also been included. Eosinophil and mast cell numbers
did not differ in the two atopic asthmatic groups. However,
eosinophil numbers were significantly elevated (P<0.01) com-
pared with the group with viral associated wheeze.
differences in age as the elevated eosinophil counts were
found when children < 5 years were studied or when exactly
age-matched subjects were compared. Our data suggests
that persistent airways inflammation is related to the pre-
sence of atopy. However, some of the children in our VAW
group, who were on average younger, may subsequently
develop atopy. In contrast, children with atopy but no
respiratory disease, did not have increased eosinophils in
their lavage fluid. Comparing our data from this study with
our previously published results from normal non-atopic
children [9]; mast cells and eosinophils were elevated in
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the atopic asthmatic but not the viral associated wheeze
group.
Both the volume return and total cell counts are in
agreement with fibreoptic bronchoscopic investigations on
adult asthmatics [17-19] and on normal and asthmatic
children [6,9,20-22]. Elevated eosinophil numbers are
found in bronchoalveolar lavage fluid from adult atopic
asthmatics compared with normals [17-19,23-25]; a find-
ing which is also reported for children with atopic asthma
[26-27]. In contrast, we and others have found that these
inflammatory cells were not elevated in the lavageate from
children who wheeze only with upper respiratory tract
infections and who have no evidence of atopy, suggesting
that atopy is an important state for the development of
persisting airways inflammation in children who wheeze
[26-28]. We have found no evidence that airways eosino-
phils and mast cells are increased in non-asthmatic atopic
children. Thus, atopy alone is not causal for this finding. It
will be important to follow-up the one non-asthmatic atopic
child who had a high BAL eosinophil count to see if he
subsequently develops asthma symptoms. A previous study
reported increased eosinophils in BAL fluid from older
asthmatics/adolescents (8-17 years) but failed to demon-
strate mast cells [6]. In our study, we used the glass cover-
slip technique [10,11] and specialized fixing and staining
methods which enabled the enumeration of mast cells.
Eosinophils were similarly elevated in atopic asthmatic
children under and over 5 years, suggesting that airways
inflammation hegins at a very early age.
Some children with atopic asthma have episodic asthma
exacerbations, whilst others have frequent symptoms per-
sisting in the intervals between asthma attacks. Our data
suggest that airways inflammation persists during relatively
asymptomatic periods in atopic children with both symptom
pattems (Fig. 2).
The immunomodulatory effect of inhaled anti-inflamma-
tory therapy on the airways is well characterized [29]. The
majority ofthe children in our atopic asthmatic group (31 of
52) were taking either inhaled corticosteroids or disodium
cromoglycate and despite this therapy we found evidence of
airways inflammation, there being no difference between
those taking/not taking anti-inflammatory therapy. This
study was not designed to determine the effects of this
treatment on BAL cell counts. From the clinical information
obtained, we considered that some of the children untreated
or on bronchodilators alone were in need of regular anti-
inflammatory therapy, thus it is therefore not possible to
conclude that those children on anti-inflammatory treatment
had more severe asthma and that the effect of this medica-
tion had been to reduce the cellular counts to similar levels
seen in those untreated or only requiring bronchodilators.
Furthermore, there was no relationship between the time of
the last symptoms and the drug treatment. It is unlikely that
the anti-inflammatory medication used in 10 of the 20
children in the group with viral associated wheeze has
caused complete suppression of airways inflammation. In
addition, some children from both groups were found to be
using inhaled corticosteroids on a 'when required' basis. We
have calculated that our study, has a 90% power to detect a
45% reduction in eosinophil numbers between atopie asth-
matic children on (n = 31) and not on (n = 21) anti-inflam-
matory therapy. We did not detect any difference. A
reduction in eosinophil numbers of 45% would be small
when considering the differences in eosinophil numbers
when atopic asthmatics are compared with VAW or non-
asthmatic atopies (Table 3).
The non-bronchoscopic lavage method used was a mod-
ification of the technique described by Koumbourlis and
Kurland [31]. We have used this method to quickly and
safely obtain bronchoalveolar lavage fluid from asthmatic
children attending for routine surgical procedures and it
causes little or no interruption to busy surgical lists.
We conclude that during relatively asymptomatic periods
on-going airways inflammation occurs in children with
atopic asthma but not in those with viral associated
wheeze without evidence of atopy. Furthermore, clinical
trials investigating new asthma medications for children
usually consider all children with wheeze as homogenous
and their design should now consider separating patients
into the different patterns of childhood asthma.
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